Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204)

NCT04463771 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT04463771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04463771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204)
Lead sponsor
Incyte Corporation
Phase
Phase 2
Overall status
Completed
Start date
January 26, 2021
Completion date
May 29, 2026
Enrollment
206 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer